Urinary organic acids test (OAT)
Other · specimen: urine
Also called: organic acids test, OAT, Great Plains organic acids test, Mosaic Diagnostics organic acids test, urine organic acid panel, metabolic urine panel
Chart note
ND-recommended test reviewed: urinary organic acids test (OAT). Indications reviewed: features of an inborn error of metabolism; not present. Not ordered. Rationale discussed: no evidence supports this panel's nutritional/dysbiosis interpretation for fatigue or GI symptoms in this context, and it risks false-positive or clinically irrelevant results. Ref: Jones, Campbell and Hart 2019, Annals of Clinical Biochemistry. Patient informed test available privately via ND. Patient given info page: https://labs.ajaxharwoodclinic.com/urinary-organic-acids/patient Revisit if: features suggestive of an inborn error of metabolism (in an infant/child, or a compatible family history) develop.
Indicated when
- Suspected inborn error of metabolism, most often in an infant or child with unexplained metabolic decompensation (lethargy, poor feeding, vomiting, unusual odour, metabolic acidosis, hypoglycemia) or a compatible family history, typically ordered by or in consultation with a metabolic genetics specialist [1]
- Follow-up or monitoring of a diagnosed organic aciduria under specialist metabolic genetics care [1]
Not indicated when
- Ordering a commercial 'organic acids test' (e.g. Great Plains/Mosaic Diagnostics) to look for 'yeast overgrowth', 'bacterial dysbiosis', or general nutritional deficiencies as an explanation for fatigue, GI symptoms, or behavioural symptoms in a patient without features suggesting an inborn error of metabolism [2]
- Interpreting the panel's proprietary marker groupings (e.g. fungal, clostridial, or oxidative-stress marker clusters) using reference ranges or explanatory frameworks that have not been independently validated
Why not
The urine organic acids test itself (GC-MS analysis) is an established, validated method for diagnosing inborn errors of metabolism in the setting it was developed for [1]. The commercial 'nutritional' or 'dysbiosis' interpretation of the same or a similar panel, marketed to look for markers of yeast or bacterial overgrowth in patients with nonspecific symptoms, is a different clinical use with a different evidence base: a review of laboratory tests used in complementary and alternative medicine found no good evidence that urine organic acid profiling is useful in diagnosing fungal overgrowth, and that screening patients with nonspecific symptoms this way carries a high risk of false-positive or clinically irrelevant results [2]. Results are often accompanied by extensive proprietary interpretation and supplement or dietary recommendations that go beyond what the underlying markers have been shown to support.
Better first step
If there is a specific concern for an inborn error of metabolism, typically in an infant or child with a compatible presentation or family history, refer to or consult metabolic genetics rather than ordering a commercial nutritional-interpretation panel. For fatigue, GI symptoms, or behavioural concerns without such features, investigate the presenting symptoms directly (diet history, standard GI work-up, sleep, mood) rather than a broad urinary metabolite panel.
Typical ND rationale
An ND may order a commercial organic acids test in a patient with fatigue, GI symptoms, or behavioural symptoms, reasoning that the panel's markers for yeast, bacterial byproducts, and nutrient cofactor status offer an objective, comprehensive window into gut and metabolic health that can guide targeted dietary and supplement treatment.
Where the ND is right
Where there is a genuine concern for an inborn error of metabolism, this class of test (validated GC-MS urine organic acid analysis) is the right one to order, ideally with metabolic genetics involved [1]. No validated situation was identified for using the same or a similar panel's proprietary 'yeast', 'dysbiosis', or nutrient-marker interpretation to guide treatment of fatigue, GI, or behavioural symptoms in patients without features of an inborn error of metabolism; a review focused on this specific use found no good supporting evidence [2].
Ontario coverage & CONO orderability
- OHIP status
- unverified
- Urinary organic acid testing does not appear by name in the 2026 Schedule of Benefits for Laboratory Services searched this session, so billing status for a physician-ordered test for suspected inborn error of metabolism is unverified; such testing, when clinically indicated, is typically arranged through a hospital metabolic genetics program rather than the community Schedule, which this session did not independently confirm. ND-ordered testing, including commercial nutritional-interpretation panels, is patient-paid regardless [4, 5].
- CONO orderable
- Yes — CONO list #168
- CONO list item 168 'Urinary Organic Acid Test'. This is the same CONO item Ontario ND clinics use to order commercial branded panels such as the Great Plains/Mosaic Diagnostics organic acids test; the CONO list does not distinguish the specialist metabolic-genetics use from the commercial nutritional-interpretation use.
Linked conditions
Counselling script
“If there's a specific concern about an inherited metabolism problem, usually flagged in infancy or childhood, this test through a metabolic genetics specialist is the right tool. Without that concern, I wouldn't order the commercial 'organic acids' version for fatigue or gut symptoms, because a review of that use found no good evidence it reliably detects yeast or bacterial overgrowth, and it can give misleading results. I'd rather look at your symptoms directly.”
Revisit if
- Features suggestive of an inborn error of metabolism develop, especially in an infant or child: metabolic decompensation, unusual odour, recurrent hypoglycemia, developmental regression, or a compatible family history
References
- [1]Villani et al. (Universita degli Studi di Napoli Federico II / CEINGE) (2017). "Classical organic acidurias": diagnosis and pathogenesis. linkUrine organic acid GC-MS analysis is the established diagnostic method for inherited organic acidurias
- [2]Jones, Campbell and Hart (Annals of Clinical Biochemistry) (2019). Laboratory tests commonly used in complementary and alternative medicine: a review of the evidence. linkNo good evidence that urine organic acid profiling detects fungal or bacterial overgrowth; screening symptomatic patients this way risks false-positive or clinically irrelevant results
- [3]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkCommunity lab tests are insured only when ordered under the Schedule by an authorized prescriber
- [4]Government of Ontario (e-Laws) (2026). Health Insurance Act, R.R.O. 1990, Reg. 552: General, s. 22 (insured laboratory services). linkInsured lab testing requires ordering by an authorized provider who has clinically assessed the patient
- [5]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkTests ordered by anyone other than an authorized provider, including NDs, are not insured services
Evidence notes
This record was not split into two ids because the specialist and commercial uses share the same underlying CONO 168 test and analytic method (urine GC-MS organic acids); the difference is in clinical indication and interpretation, not a different test, protocol, or specimen, matching the CONO-branded-panel precedent from the adrenal-pilot lessons rather than the 'different protocol, panel or specimen' split criterion. Whether Ontario's metabolic genetics programs order this test through a hospital lab outside the community Schedule was not independently confirmed this session. Reviewer: verdict changed from specific to rarely, consistent with other specialist-only tests (fibrinogen, fasting insulin, amino acids). The validated use is metabolic-genetics work-up, not a primary-care order.